Skip to main content
main-content

Cardiology

Cardiology

03-03-2017 | Interventional cardiology | News | Article

No benefit of ischemic postconditioning during PCI

Results of the DANAMI-3–iPOST trial suggest that ischemic postconditioning during percutaneous coronary intervention does not improve clinical outcome for patients with ST-segment elevation myocardial infarction.

03-03-2017 | Pulmonary hypertension | News | Article

Right atrial strain associated with clinical outcomes in PAH

Study results suggest that right atrial strain could predict adverse outcomes among patients with pulmonary arterial hypertension.

02-03-2017 | Interventional cardiology | News | Article

Benefits of complete versus target-only revascularization examined in multivessel CAD

Results of a meta-analysis suggest that complete revascularization is associated with a reduced risk for cardiac events, but not overall mortality, among patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease.

01-03-2017 | Arrhythmia | News | Article

No reduction in AF recurrence with aggressive blood pressure treatment

Reducing target blood pressure does not decrease the incidence of recurrent arrhythmia among patients undergoing catheter ablation for atrial fibrillation, results of a randomized trial suggest.

24-02-2017 | Cardiology | News | Article

No reduction in intraoperative bleeding with fibrinogen concentrate

Results of a randomized trial published in JAMA suggest that infusion of fibrinogen concentrate does not reduce intraoperative blood loss during high-risk cardiac surgery.

23-02-2017 | Cardiology | News | Article

Mediterranean diet may improve HDL atheroprotective functions

Adherence to a traditional Mediterranean diet could improve the atheroprotective functions of high-density lipoprotein among people with high cardiovascular risk, results from a substudy of the PREDIMED trial suggest.

21-02-2017 | Interventional cardiology | News | Article

Transradial CTO PCI may be feasible for noncomplex cases

Transradial percutaneous coronary intervention could be feasible for the treatment of noncomplex chronic total occlusions, but complex cases may require a transfemoral approach, Japanese researchers report.

17-02-2017 | Interventional cardiology | News | Article

Similar outcomes with BMS and DES in myocardial infarction with cardiogenic shock

Study results suggest that patients with acute myocardial infarction complicated by cardiogenic shock have similar outcomes when treated with drug-eluting or bare metal stents.

16-02-2017 | Arrhythmia | Main feed | Article

Real-world effectiveness, safety of novel oral anticoagulants in AF explored

A Danish nationwide cohort study published in The BMJ examines the effectiveness and safety profiles of novel oral anticoagulants among patients with atrial fibrillation.

15-02-2017 | Heart failure | News | Article

Elevated hs-cTnT levels could indicate subclinical cardiac disease

Minor increases in high-sensitivity cardiac troponin T levels may represent an early biochemical signature of subclinical heart disease, researchers report.

13-02-2017 | Hypertension | News | Article

Quarter-dose quadpill a promising antihypertensive approach

A pilot randomized crossover trial suggests that giving patients a single pill composed of four antihypertensives at a quarter of their usual dose is a promising means of controlling blood pressure.

10-02-2017 | Interventional cardiology | Highlight | Article

Steady long-term risk of late events with first-generation DES

Patients with first-generation drug-eluting coronary stents remain at risk for late adverse events, say researchers who report the 10-year outcomes of the Danish all-comer SORT OUT II trial.

08-02-2017 | Stroke | Highlight | Article

Prolonged ECG monitoring improves post-stroke atrial fibrillation detection

Research suggests that all patients aged 60 years or older who have had a stroke, irrespective of the suspected cause, could benefit from enhanced and prolonged monitoring for atrial fibrillation.

06-02-2017 | Interventional cardiology | News | Article

Health benefits of TAVR extend beyond the trial setting

Study results suggest that the health status benefits of transcatheter aortic valve replacement that have been observed in clinical trials extend to real-world clinical practice.

01-02-2017 | Interventional cardiology | News | Article

Meta-analysis raises further concerns about bioresorbable scaffolds

The results of a meta-analysis add to evidence suggesting that bioresorbable vascular scaffolds are associated with unfavorable clinical outcomes compared with drug-eluting stents among patients with coronary artery disease.

31-01-2017 | Interventional cardiology | News | Article

No benefit of routine follow-up angiography after PCI

Results of the ReACT trial suggest no additional benefit with follow-up coronary angiography after percutaneous coronary intervention in daily clinical practice.

27-01-2017 | Cardiology | News | Article

Globorisk expands CVD risk estimates to 182 countries

The Globorisk project has published charts for the cardiovascular disease risk assessment of people in 182 countries.

27-01-2017 | Emergency medicine | News | Article

Early tracheal intubation after cardiac arrest contested

Study results published in JAMA suggest that tracheal intubation performed within the first 15 minutes of in-hospital cardiac arrest is associated with decreased survival compared with no intubation during this timeframe.

26-01-2017 | Coronary heart disease | News | Article

Broad use of RAS inhibitors in patients with coronary artery disease may not be justified

Results of a meta-analysis suggest no benefit of treatment with renin angiotensin system inhibitors compared with active controls in patients with stable coronary artery disease without heart failure.

26-01-2017 | Neurology | News | Article

Insufficient evidence prevents OSA screening recommendation

The US Preventive Services Task Force has issued an “I” statement regarding screening for obstructive sleep apnea in adults, concluding that the current evidence is insufficient to assess the balance of benefits and harms.

Image Credits